Jacques Marbehant – Senior Vice President, Head of Global Manufacturing,…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Address: Prince Boudewijnlaan 24C
2550 Kontich,Belgium
Tel: +32-3-450 81 60
Web: http://www.vsm.be/
VSM is a specialist in the field of high quality natural medicines. VSM Belgium offers an extensive range of phytotherapeutic and homeopathic products for many common diseases and ailments. These products are exclusively distributed in Belgium through pharmacies – whether or not prescribed by a doctor. All of VSM’s drugs meet the requirements of Belgian law, and therefore their quality and safety guaranteed. VSM Belgium is one of dozens of subsidiaries of Dr.Willmar Schwabe Group and has been present in Belgium since 1992. Our offices are located in Kontich (Antwerp).
A range of phytotherapeutic and homeopathic including: Calmiplant® and Dormiplant® Mono, Kaloban®, Perika® and Venoplant®.
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…